PD-L1 targeting in triple negative breast cancer: in silico and in vitro validation of wasp venom peptide MP-1.

Saved in:
Bibliographic Details
Title: PD-L1 targeting in triple negative breast cancer: in silico and in vitro validation of wasp venom peptide MP-1.
Authors: Sakhawat A; Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan., Khan MU; Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. Muhammad.umer4@mlt.uol.edu.pk., Khan S; Faculty of Health and Life Sciences, INTI International University, Persiaran Perdana, BBN Putra Nilai, 71800, Nilai, Negeri Sembilan, Malaysia.; Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore , Pakistan., Ahmed N; Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan., Alhegaili AS; Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, 11942, Al-Kharj, Saudi Arabia., Alotaibi BS; Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.
Source: Medical oncology (Northwood, London, England) [Med Oncol] 2025 Nov 24; Vol. 43 (1), pp. 14. Date of Electronic Publication: 2025 Nov 24.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1559-131X
DOI:10.1007/s12032-025-03133-1